Stevanato Group announced lower-than-expected volumes and revenue from GLP-1 therapies for 2027, which previously accounted for about 17-18% of its Q3 revenue. This revision led to a 28.57% drop in its stock price, raising concerns about the company's prior growth outlook and investor disclosures. The law firm Kehoe is investigating potential shareholder claims related to these developments. Investors who suffered losses are encouraged to seek legal advice.
Stevanato Group's shareholder investigation follows a significant stock price drop. For readers following the Health sector, here is Pluang's market snapshot as of Nov 04, 2026 19:41 WIB: out of 150 priced US Health stocks, 121 rose and 23 fell. Notable movers include TLRY at USD 2.77 (+4.53%), VRTX at USD 554.38 (+4.45%), and SYRE at USD 95.04 (-4.26%).
Sutro Biopharma, a clinical-stage oncology company specializing in antibody drug conjugates (ADCs), announced its participation in several investor conferences in November and December 2026, including events hosted by Stifel, Truist Securities, UBS, ...
etoro has agreed to acquire LB Finanzas, a leading Argentine all-in-one financial app, to strengthen its presence in Latin America's fast-growing fintech market. LB Finanzas offers integrated investing and payment solutions, catering to Argentine ret...
JD.com announced it will publish its unaudited financial results for the third quarter of 2026 on November 17, before the U.S. market opens. The company's management will hold a conference call the same day to discuss the results, providing investors...
KE Holdings Inc., a major online and offline housing platform in China, will announce its unaudited financial results for the third quarter of 2026 on November 16 before the U.S. market opens. The company will host an earnings conference call at 7:00...
Dimensional Fund Advisors Ltd. filed a Form 8.3 disclosure revealing it holds a 1.27% stake in Prologis Inc as of November 3, 2026. This disclosure is part of regulatory requirements under the Takeover Code for investors holding 1% or more in relevan...
